Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB8 | P28062 | 2/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13257737 | 0.89 | KMT2A (0.33) | PSMB8PSMB5MGLL | |
| SCHEMBL43576 | 0.87 | PSMB8 (0.35) | PSMB8PSMB5MGLLLMNA | |
| SCHEMBL18170352 | 0.85 | SMN1; SMN2 (0.38) | PSMB8PSMB5 | |
| SCHEMBL28630993 | 0.85 | SMN1; SMN2 (0.38) | PSMB8PSMB5 | |
| SCHEMBL1508845 | 0.85 | SMN1; SMN2 (0.38) | PSMB8PSMB5 | |
| SCHEMBL31522720 | 0.85 | PSMB8 (0.34) | PSMB8PSMB5MGLLLMNA | |
| Mercaptopropionic Acid SCHEMBL1014492 | 0.84 | TSHR (0.35) | PSMB8PSMB5ACE | |
| SCHEMBL22777675 | 0.83 | SMN1; SMN2 (0.36) | PSMB8PSMB5MGLLLMNA | |
| SCHEMBL2244117 | 0.83 | TSHR (0.36) | MGLL | |
| SCHEMBL34383 | 0.83 | SMN1; SMN2 (0.36) | PSMB8PSMB5MGLLLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250041306-A1 | TARGETED PROTEASE DEGRADATION (TED) PLATFORM | EUBULUS BIOTHERAPEUTICS INC. (CN) | 2025-02-06 | — | — | US | disclosed |
| CN-118119623-A | Targeted protease degradation (TED) platform | 嘉兴优博生物技术有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-115364243-B | Construction and application of visual regulation probe for T cell immunocompetence | 厦门大学 | 2024-05-31 | — | — | CN | disclosed |
| CN-113929738-B | Antibody-drug conjugates | 第一三共株式会社 | 2024-05-17 | — | — | CN | disclosed |
| US-11945848-B2 | Chimeric inhibitor molecules of complement activation | OMEROS CORPORATION (US) | 2024-04-02 | — | — | US | disclosed |
| US-20240082413-A1 | ANTIBODY-DRUG CONJUGATE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2024-03-14 | — | — | US | disclosed |
| US-11911999-B2 | Plasmonic patch as a universal fluorescence enhancer | WASHINGTON UNIVERSITY (US) | 2024-02-27 | — | — | US | disclosed |
| US-20230295252-A1 | CHIMERIC INHIBITOR MOLECULES OF COMPLEMENT ACTIVATION | OMEROS CORPORATION (US) | 2023-09-21 | — | — | US | disclosed |
| US-20230249441-A9 | PLASMONIC PATCH AS A UNIVERSAL FLUORESCENCE ENHANCER | WASHINGTON UNIVERSITY | 2023-08-10 | — | — | US | disclosed |
| CN-109081871-B | Antibody-drug conjugates | 第一三共株式会社 | 2023-07-14 | — | — | CN | disclosed |
| US-20110130550-A1 | PROTEIN MONOMER, PROTEIN POLYMER OBTAINED FROM SAID MONOMER, AND DEVICE THAT CONTAINS THEM | OSAKA UNIVERSITY (JP) | 2011-06-02 | — | — | US | disclosed |
| US-7724373-B2 | Sub-micron surface plasmon resonance sensor systems | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-05-25 | — | — | US | disclosed |
| WO-2008100161-A9 | SURFACE PLASMON RESONANCE ASSAY FOR STEROIDS | THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED (NZ) | 2009-09-11 | — | — | WO | disclosed |
| US-20090081153-A1 | COMBINATION OF SYNTHETIC ANTIMICROBIAL POLYMERS AND SESQUITERPENOID COMPOUNDS | POLYMEDIX, INC. (US) | 2009-03-26 | — | — | US | disclosed |
| US-20090081153-A1 | COMBINATION OF SYNTHETIC ANTIMICROBIAL POLYMERS AND SESQUITERPENOID COMPOUNDS | POLYMEDIX, INC. (US) | 2009-03-26 | — | — | US | disclosed |
| WO-2008100161-A1 | SURFACE PLASMON RESONANCE ASSAY FOR STEROIDS | THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED (NZ) | 2008-08-21 | — | — | WO | disclosed |
| US-20070153284-A1 | Sub-Micron Surface Plasmon Resonance Sensor Systems | THE TRUSTEES OF INDIANA UNIVERSITY | 2007-07-05 | — | — | US | disclosed |
| US-20060105948-A1 | GLP-2 derivatives | NOVO NORDISK A/S (DK) | 2006-05-18 | — | — | US | disclosed |
| EP-1608680-A2 | GLP-2 DERIVATIVES | NOVO NORDISK A/S (DK) | 2005-12-28 | — | — | EP | disclosed |
| WO-2004085471-A2 | GLP-2 DERIVATIVES | NOVO NORDISK A/S (DK) | 2004-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250041306-A1 | TARGETED PROTEASE DEGRADATION (TED) PLATFORM | ADAMTS1, UCHL3, ADAM33 | PSMB8 173/4885PSMB5 264/4885MGLL 1995/4885 |
| US-20060105948-A1 | GLP-2 derivatives | GLP1R, GIPR, IAPP | PSMB8 3580/4885PSMB5 2724/4885MGLL 251/4885 |
| US-20110130550-A1 | PROTEIN MONOMER, PROTEIN POLYMER OBTAINED FROM SAID MONOMER, AND DEVICE THAT CONTAINS THEM | MAX, MLX, MRPL21 | PSMB8 931/4885PSMB5 1151/4885MGLL 1764/4885 |
| US-20090081153-A1 | COMBINATION OF SYNTHETIC ANTIMICROBIAL POLYMERS AND SESQUITERPENOID COMPOUNDS | LSS, PUF60, FDPS | PSMB8 2374/4885PSMB5 1589/4885MGLL 529/4885 |
| US-20240082413-A1 | ANTIBODY-DRUG CONJUGATE | LANCL2, LANCL1, LCLAT1 | PSMB8 1278/4885PSMB5 822/4885MGLL 298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.